Surgical robot titan Sagebot given go-ahead to list on SSE STAR Market

The float represents no less than 25% of the company's total capital stock, according to Sagebot's prospectus which it filed with the SSE last October.

Chinese financial media reported today that Sagebot (思哲睿智能医疗), a domestic surgical robot leader, has been given the greenlight to go public on Shanghai Stock Exchange’s Nasdaq-style STAR Market, said a notice issued by the listing committee on June 1.

Often dubbed China’s answer to Intuitive Surgical’s da Vinci system, Sagebot plans to raise 2.029 billion yuan (US$285 million) from the sale of no more than 50 million shares, with CITIC Securities as the sponsor.

The float represents no less than 25% of the company’s total capital stock, according to Sagebot’s prospectus which it filed with the SSE last October.

Proceeds from the IPO will be used to facilitate R&D of surgical robots, commercialize projects, construct a distribution network, and supplement the firm’s working capital.

Founded in 2013 by Professor Du Zhijiang of Harbin Institute of Technology, Sagebot is among the country’s first firms to engage in the design, development, manufacturing and sale of endoscopic surgical robots.

Since its inception, Sagebot has completed several rounds of funding, backed by well-known investors such as Shenzhen Capital Group, Boshi, Essence Securities, Harbin Venture Capital Group.

Its pre-IPO valuation exceeded 8.3 billion yuan and was recognized as a unicorn of Harbin, its birthplace.

cnrobopedia reported last week that Sagebot’s staple products, an endoscopic robot series called Kangduo, were the first such devices to enter the specialized screening procedure for urological medical equipment.

The series landed a certificate from National Medical Product Administration (NMPA) in June 2022.

Kangduo is also the country’s first type of domestically produced endoscopic robots to complete 100 surgical clinical trials at a single hospital.

It achieved the first commercial installation in February 2023. A month later, the first Kangduo robot was adopted at a non-public domestic hospital.

Avatar photo
Ni Tao

Ni Tao is the founder and editor-in-chief of cnrobopedia. Prior to cnrobopedia, he had a full decade of experience with a major state-run English-language newspaper as a tech reporter and opinion writer. He is also a communications specialist, having provided consultancy services to established firms like Siemens, Philips, ABinBev, Diageo, Group (Nasdaq: TCOM, HK: 9961), Jianpu Technology (NYSE: JT) and a handful of domestic startups. A graduate of Fudan University, he writes widely about China's business and tech scenes and other topics for global publications including South China Morning Post, SupChina, The Diplomat, CGTN, Banking Technology, among others, and tries to impart his experience to students at Fudan University Journalism School, where he is a part-time lecturer. When he's not writing about robotics, you can expect him to be on his beloved Yanagisawa saxophones, trying to play some jazz riffs, often in vain and occasionally against the protests of an angry neighbor. Get in touch with him by dropping a line at

Articles: 678